Merck Announces Phase 3 KEYNOTE-522 Trial Met its Overall Survival (OS) Endpoint in Patients With High-Risk Early-Stage Triple Negative Breast Cancer (TNBC)
KEYTRUDA® (pembrolizumab) is the first and only immunotherapy-based regimen to show a statistically significant improvement in OS as pre-operative (neoadjuvant)... Read more.
The BlackRock Foundation invests in Spartanburg Academic Movement to spur education and job readiness in Union County, South Carolina
With Union County Schools and other partners, SAM will develop cradle-to-career program to boost local workforce SPARTANBURG, S.C.–(BUSINESS WIRE)–Spartanburg... Read more.
CORE Industrial Partners Portfolio Company PrecisionX Group Acquires National Manufacturing
CHICAGO–(BUSINESS WIRE)–CORE Industrial Partners (“CORE”), a manufacturing, industrial technology, and industrial services-focused private equity... Read more.
Arcturus Therapeutics Announces Positive Development for Cystic Fibrosis Program
Arcturus to present new Phase 1b interim data for ARCT-032 at European Cystic Fibrosis Conference on June 7, 2024 First four CF patients demonstrated an average... Read more.
IHS Towers Publishes 2023 Sustainability Report
LONDON–(BUSINESS WIRE)–IHS Holding Limited (NYSE: IHS) (“IHS Towers”) group, one of the largest independent owners, operators, and developers of... Read more.
Arrowhead Pharmaceuticals Presents New Phase 2 Data of Plozasiran in Patients with Mixed Hyperlipidemia
– Plozasiran significantly lowered triglyceride levels with commensurate reductions in APOC3, non-HDL-C, and remnant cholesterol – Data presented at... Read more.
Insulet to Present at the Jefferies Global Healthcare Conference
ACTON, Mass.–(BUSINESS WIRE)–Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® brand... Read more.
Amid Rapid Growth, Industry Veteran Paul Barnes Appointed as CEO of CWH Advisors
BOSTON–(BUSINESS WIRE)–CWH Advisors, a leading healthcare management consulting firm, today announced the appointment of Paul Barnes, Ph.D., as its new... Read more.
Biodesix to Participate in Two Investor Conferences in June
LOUISVILLE, Colo.–(BUSINESS WIRE)–$BDSX #patientsfirst—Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung... Read more.
OpsMill Transforms Infrastructure Automation with Beta Release of Open Source Infrahub
Infrahub brings the worlds of infrastructure-as-code and infrastructure management together in a single platform PARIS–(BUSINESS WIRE)–OpsMill, a pioneer... Read more.